NFU

FDA approves remdesevir as “first drug for COVID-19,” despite WHO trial showing no benefit

Post author By MCM
Post date October 22, 2020
No Comments on FDA approves remdesevir as “first drug for COVID-19,” despite WHO trial showing no benefit

Another way to bury HCQ.

(Thank you, Pres. Trump!)

Article link: https://www.medpagetoday.com/infectiousdisease/covid19/89281

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.